NEW YORK (GenomeWeb News) – Investigators at the Polytechnic Institute of New York University and NYU plan to use a $1.2 million grant from the National Institutes of Health to study how histones may be involved in cancer and diabetes, NYU-Poly said today.

The research team plans to use computational chemistry and protein engineering approaches to study these scaffolding proteins, which are modified by enzymes called histone acetyltransferases, or HATs. Those changes can then affect gene expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."